I Y Kim

Summary

Affiliation: New Jersey
Country: USA

Publications

  1. pmc Bone morphogenetic protein signaling: implications in urology
    Jeongyun Jeong
    Department of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
    Korean J Urol 51:511-7. 2010
  2. doi request reprint Radium Ra 223 dichloride in castration-resistant prostate cancer
    J Y Joung
    Section of Urologic Oncology and the Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA Department of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Korea
    Drugs Today (Barc) 49:483-90. 2013
  3. ncbi request reprint Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study
    Isaac Yi Kim
    Section of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, USA
    J Urol 190:527-34. 2013
  4. ncbi request reprint Role of bone morphogenetic proteins in transitional cell carcinoma cells
    Isaac Yi Kim
    Division of Urologic Oncology, The Cancer Institute of New Jersey, 195 Little Albany Street 4560, New Brunswick, NJ 08903, USA
    Cancer Lett 241:118-23. 2006
  5. doi request reprint Enzalutamide for the treatment of castration-resistant prostate cancer
    Y S Ha
    Section of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA
    Drugs Today (Barc) 49:7-13. 2013
  6. pmc Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction
    G T Lee
    Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Rutgers, The State University of New Jersey, 195 Little Albany Street no 4560, New Brunswick, NJ 08901, USA
    Br J Cancer 110:1634-44. 2014
  7. ncbi request reprint Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey
    J H Kim
    1 Section of Urologic Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA 2 Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea
    Prostate Cancer Prostatic Dis 16:341-5. 2013

Collaborators

Detail Information

Publications7

  1. pmc Bone morphogenetic protein signaling: implications in urology
    Jeongyun Jeong
    Department of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
    Korean J Urol 51:511-7. 2010
    ..In this article, we discuss various mechanisms involved in regulating BMP signaling pathways and their implications for urology...
  2. doi request reprint Radium Ra 223 dichloride in castration-resistant prostate cancer
    J Y Joung
    Section of Urologic Oncology and the Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA Department of Urology, Center for Prostate Cancer, National Cancer Center, Goyang, Korea
    Drugs Today (Barc) 49:483-90. 2013
    ..6 months when compared to the placebo group. Collectively, these results suggest that radium Ra 223 dichloride is a promising candidate for managing bone metastases in patients with CRPC. ..
  3. ncbi request reprint Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study
    Isaac Yi Kim
    Section of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, Cancer Institute of New Jersey, New Brunswick, New Jersey 08903, USA
    J Urol 190:527-34. 2013
    ..We identified the perioperative characteristics and assessed the clinical outcomes of patients with prostatic anterior fat pad lymph node metastasis...
  4. ncbi request reprint Role of bone morphogenetic proteins in transitional cell carcinoma cells
    Isaac Yi Kim
    Division of Urologic Oncology, The Cancer Institute of New Jersey, 195 Little Albany Street 4560, New Brunswick, NJ 08903, USA
    Cancer Lett 241:118-23. 2006
    ..Herein, we review the data concerning BMPs in transitional cell carcinoma cells...
  5. doi request reprint Enzalutamide for the treatment of castration-resistant prostate cancer
    Y S Ha
    Section of Urologic Oncology and Dean and Betty Gallo Prostate Cancer Center, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA
    Drugs Today (Barc) 49:7-13. 2013
    ..Currently, a phase III trial (PREVAIL) is under way to determine the effectiveness of enzalutamide in patients who have not received prior docetaxel chemotherapy...
  6. pmc Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction
    G T Lee
    Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Rutgers, The State University of New Jersey, 195 Little Albany Street no 4560, New Brunswick, NJ 08901, USA
    Br J Cancer 110:1634-44. 2014
    ..In the present study, we have investigated the role of bone morphogenetic protein-6 (BMP-6) in the development of castration-resistant prostate cancer (CRPC) in the context of bone metastases...
  7. ncbi request reprint Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite survey
    J H Kim
    1 Section of Urologic Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA 2 Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea
    Prostate Cancer Prostatic Dis 16:341-5. 2013
    ..We investigated variables that were associated with patient-perceived satisfaction after RARP using the expanded prostate cancer index composite (EPIC) survey...